297 related articles for article (PubMed ID: 35534717)
1. A brief history of brain iron accumulation in Parkinson disease and related disorders.
Foley PB; Hare DJ; Double KL
J Neural Transm (Vienna); 2022 Jun; 129(5-6):505-520. PubMed ID: 35534717
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
[TBL] [Abstract][Full Text] [Related]
3. Anatomy and pathology of extrapyramidal diseases.
Seab JA
Brain Res Bull; 1983 Aug; 11(2):135-41. PubMed ID: 6226338
[TBL] [Abstract][Full Text] [Related]
4. Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia.
Dexter DT; Sian J; Jenner P; Marsden CD
Adv Neurol; 1993; 60():273-81. PubMed ID: 8420143
[No Abstract] [Full Text] [Related]
5. Neuroimaging in basal ganglia disorders: perspectives for transcranial ultrasound.
Becker G; Berg D
Mov Disord; 2001 Jan; 16(1):23-32. PubMed ID: 11215589
[TBL] [Abstract][Full Text] [Related]
6. Lateral Asymmetry and Spatial Difference of Iron Deposition in the Substantia Nigra of Patients with Parkinson Disease Measured with Quantitative Susceptibility Mapping.
Azuma M; Hirai T; Yamada K; Yamashita S; Ando Y; Tateishi M; Iryo Y; Yoneda T; Kitajima M; Wang Y; Yamashita Y
AJNR Am J Neuroradiol; 2016 May; 37(5):782-8. PubMed ID: 26822728
[TBL] [Abstract][Full Text] [Related]
7. The history of the research of iron in parkinsonian substantia nigra.
Friedman A; Galazka-Friedman J
J Neural Transm (Vienna); 2012 Dec; 119(12):1507-10. PubMed ID: 22941506
[TBL] [Abstract][Full Text] [Related]
8. Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease.
Hochstrasser H; Bauer P; Walter U; Behnke S; Spiegel J; Csoti I; Zeiler B; Bornemann A; Pahnke J; Becker G; Riess O; Berg D
Neurology; 2004 Nov; 63(10):1912-7. PubMed ID: 15557511
[TBL] [Abstract][Full Text] [Related]
9. Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.
Ferrer I; Martinez A; Blanco R; Dalfó E; Carmona M
J Neural Transm (Vienna); 2011 May; 118(5):821-39. PubMed ID: 20862500
[TBL] [Abstract][Full Text] [Related]
10. [MRI of degenerative extrapyramidal syndromes. Parkinson disease, progressive supranuclear palsy and multiple system atrophy].
Elkeslassy A; Miaux Y; Martin-Duverneuil N; Brunet E; Savin D; Chiras J
J Neuroradiol; 1996 Dec; 23(3):157-63. PubMed ID: 9091608
[TBL] [Abstract][Full Text] [Related]
11. Application of transcranial sonography in extrapyramidal disorders: updated recommendations.
Berg D; Behnke S; Walter U
Ultraschall Med; 2006 Feb; 27(1):12-9. PubMed ID: 16470475
[TBL] [Abstract][Full Text] [Related]
12. [Neuraminergic conception of extrapyramidal syndromology].
Levin SL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(2):293-9. PubMed ID: 139066
[No Abstract] [Full Text] [Related]
13. Iron, the substantia nigra and related neurological disorders.
Snyder AM; Connor JR
Biochim Biophys Acta; 2009 Jul; 1790(7):606-14. PubMed ID: 18778755
[TBL] [Abstract][Full Text] [Related]
14. [Rare extrapyramidal disorders: progressive supranuclear paralysis and striato-nigral degeneration].
Marttila R; Kalimo H; Nikoskelainen E; Rinne UK
Duodecim; 1982; 98(3):191-200. PubMed ID: 7060514
[No Abstract] [Full Text] [Related]
15. Extra-basal ganglia iron content and non-motor symptoms in drug-naïve, early Parkinson's disease.
Kim M; Yoo S; Kim D; Cho JW; Kim JS; Ahn JH; Mun JK; Choi I; Lee SK; Youn J
Neurol Sci; 2021 Dec; 42(12):5297-5304. PubMed ID: 33860863
[TBL] [Abstract][Full Text] [Related]
16. Severity of restless legs syndrome is inversely correlated with echogenicity of the substantia nigra in different neurodegenerative movement disorders. a preliminary observation.
Pedroso JL; Bor-Seng-Shu E; Felicio AC; Braga-Neto P; Dutra LA; de Aquino CC; Ferraz HB; do Prado GF; Teixeira MJ; Barsottini OG
J Neurol Sci; 2012 Aug; 319(1-2):59-62. PubMed ID: 22632781
[TBL] [Abstract][Full Text] [Related]
17. Nervous mechanisms involved in experimentally induced extrapyramidal disturbances.
Poirier LJ
Confin Neurol; 1974; 36(4-6):223-36. PubMed ID: 4218801
[No Abstract] [Full Text] [Related]
18. Adaptive cellular response of the substantia nigra dopaminergic neurons upon age-dependent iron accumulation.
Kwon K; Cho H; Lee S; Cho EJ; Yu W; Kok CYL; Je HS; Kim JI; Cho HJ; Kwon T
Aging Cell; 2022 Sep; 21(9):e13694. PubMed ID: 35984750
[TBL] [Abstract][Full Text] [Related]
19. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains.
Sofic E; Paulus W; Jellinger K; Riederer P; Youdim MB
J Neurochem; 1991 Mar; 56(3):978-82. PubMed ID: 1704426
[TBL] [Abstract][Full Text] [Related]
20. Differential Effect of Iron and Myelin on Susceptibility MRI in the Substantia Nigra.
Lee H; Cho H; Lee MJ; Kim TH; Roh J; Lee JH
Radiology; 2021 Dec; 301(3):682-691. PubMed ID: 34609198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
